139 related articles for article (PubMed ID: 36001773)
1. Skeletal Muscle is a Source of α-Synuclein with a Sarcolemmal Non-Lipid Raft Distribution.
Ramirez-Soto I; Ortega-Aguilar A
Cell Physiol Biochem; 2022 Aug; 56(4):382-400. PubMed ID: 36001773
[TBL] [Abstract][Full Text] [Related]
2. Identification of synaptosomal proteins binding to monomeric and oligomeric α-synuclein.
Betzer C; Movius AJ; Shi M; Gai WP; Zhang J; Jensen PH
PLoS One; 2015; 10(2):e0116473. PubMed ID: 25659148
[TBL] [Abstract][Full Text] [Related]
3. Part II: alpha-synuclein and its molecular pathophysiological role in neurodegenerative disease.
Dev KK; Hofele K; Barbieri S; Buchman VL; van der Putten H
Neuropharmacology; 2003 Jul; 45(1):14-44. PubMed ID: 12814657
[TBL] [Abstract][Full Text] [Related]
4. Plasma alpha-synuclein is decreased in subjects with Parkinson's disease.
Li QX; Mok SS; Laughton KM; McLean CA; Cappai R; Masters CL; Culvenor JG; Horne MK
Exp Neurol; 2007 Apr; 204(2):583-8. PubMed ID: 17258710
[TBL] [Abstract][Full Text] [Related]
5. How epigallocatechin gallate binds and assembles oligomeric forms of human alpha-synuclein.
Andersen CB; Yoshimura Y; Nielsen J; Otzen DE; Mulder FAA
J Biol Chem; 2021; 296():100788. PubMed ID: 34019875
[TBL] [Abstract][Full Text] [Related]
6. The N-terminus of α-synuclein is essential for both monomeric and oligomeric interactions with membranes.
Lorenzen N; Lemminger L; Pedersen JN; Nielsen SB; Otzen DE
FEBS Lett; 2014 Jan; 588(3):497-502. PubMed ID: 24374342
[TBL] [Abstract][Full Text] [Related]
7. Dihydromyricetin Inhibits α-Synuclein Aggregation, Disrupts Preformed Fibrils, and Protects Neuronal Cells in Culture against Amyloid-Induced Cytotoxicity.
Jia L; Wang Y; Sang J; Cui W; Zhao W; Wei W; Chen B; Lu F; Liu F
J Agric Food Chem; 2019 Apr; 67(14):3946-3955. PubMed ID: 30900456
[TBL] [Abstract][Full Text] [Related]
8. Oleuropein derivatives from olive fruit extracts reduce α-synuclein fibrillation and oligomer toxicity.
Mohammad-Beigi H; Aliakbari F; Sahin C; Lomax C; Tawfike A; Schafer NP; Amiri-Nowdijeh A; Eskandari H; Møller IM; Hosseini-Mazinani M; Christiansen G; Ward JL; Morshedi D; Otzen DE
J Biol Chem; 2019 Mar; 294(11):4215-4232. PubMed ID: 30655291
[TBL] [Abstract][Full Text] [Related]
9. Lipid Peroxidation Products HNE and ONE Promote and Stabilize Alpha-Synuclein Oligomers by Chemical Modifications.
Andersen C; Grønnemose AL; Pedersen JN; Nowak JS; Christiansen G; Nielsen J; Mulder FAA; Otzen DE; Jørgensen TJD
Biochemistry; 2021 Nov; 60(47):3644-3658. PubMed ID: 34730940
[TBL] [Abstract][Full Text] [Related]
10. Characterizing the dynamics of α-synuclein oligomers using hydrogen/deuterium exchange monitored by mass spectrometry.
Mysling S; Betzer C; Jensen PH; Jorgensen TJ
Biochemistry; 2013 Dec; 52(51):9097-103. PubMed ID: 24191706
[TBL] [Abstract][Full Text] [Related]
11. High stability and cooperative unfolding of α-synuclein oligomers.
Paslawski W; Andreasen M; Nielsen SB; Lorenzen N; Thomsen K; Kaspersen JD; Pedersen JS; Otzen DE
Biochemistry; 2014 Oct; 53(39):6252-63. PubMed ID: 25216651
[TBL] [Abstract][Full Text] [Related]
12. α-Synuclein-induced synapse damage in cultured neurons is mediated by cholesterol-sensitive activation of cytoplasmic phospholipase A2.
Bate C; Williams A
Biomolecules; 2015 Mar; 5(1):178-93. PubMed ID: 25761116
[TBL] [Abstract][Full Text] [Related]
13. Platelet alpha- and gamma-synucleins in Parkinson's disease and normal control subjects.
Li QX; Campbell BC; McLean CA; Thyagarajan D; Gai WP; Kapsa RM; Beyreuther K; Masters CL; Culvenor JG
J Alzheimers Dis; 2002 Aug; 4(4):309-15. PubMed ID: 12446933
[TBL] [Abstract][Full Text] [Related]
14. The potential of zwitterionic nanoliposomes against neurotoxic alpha-synuclein aggregates in Parkinson's Disease.
Aliakbari F; Mohammad-Beigi H; Rezaei-Ghaleh N; Becker S; Dehghani Esmatabad F; Eslampanah Seyedi HA; Bardania H; Tayaranian Marvian A; Collingwood JF; Christiansen G; Zweckstetter M; Otzen DE; Morshedi D
Nanoscale; 2018 May; 10(19):9174-9185. PubMed ID: 29725687
[TBL] [Abstract][Full Text] [Related]
15. Cholesterol depletion uncouples β-dystroglycans from discrete sarcolemmal domains, reducing the mechanical activity of skeletal muscle.
Vega-Moreno J; Tirado-Cortes A; Álvarez R; Irles C; Mas-Oliva J; Ortega A
Cell Physiol Biochem; 2012; 29(5-6):905-18. PubMed ID: 22613990
[TBL] [Abstract][Full Text] [Related]
16. Non-Abeta component of Alzheimer's disease amyloid (NAC) revisited. NAC and alpha-synuclein are not associated with Abeta amyloid.
Culvenor JG; McLean CA; Cutt S; Campbell BC; Maher F; Jäkälä P; Hartmann T; Beyreuther K; Masters CL; Li QX
Am J Pathol; 1999 Oct; 155(4):1173-81. PubMed ID: 10514400
[TBL] [Abstract][Full Text] [Related]
17. Thymoquinone protects cultured hippocampal and human induced pluripotent stem cells-derived neurons against α-synuclein-induced synapse damage.
Alhebshi AH; Odawara A; Gotoh M; Suzuki I
Neurosci Lett; 2014 Jun; 570():126-31. PubMed ID: 24080376
[TBL] [Abstract][Full Text] [Related]
18. The primary neuronal cells are more resistant than PC12 cells to α-synuclein toxic aggregates.
Heravi M; Dargahi L; Parsafar S; Tayaranian Marvian A; Aliakbari F; Morshedi D
Neurosci Lett; 2019 May; 701():38-47. PubMed ID: 30776494
[TBL] [Abstract][Full Text] [Related]
19. The status of the terminal regions of α-synuclein in different forms of aggregates during fibrillization.
Marvian AT; Aliakbari F; Mohammad-Beigi H; Ahmadi ZA; Mehrpooyan S; Lermyte F; Nasouti M; Collingwood JF; Otzen DE; Morshedi D
Int J Biol Macromol; 2020 Jul; 155():543-550. PubMed ID: 32240735
[TBL] [Abstract][Full Text] [Related]
20. Interactions of α-synuclein oligomers with lipid membranes.
Musteikytė G; Jayaram AK; Xu CK; Vendruscolo M; Krainer G; Knowles TPJ
Biochim Biophys Acta Biomembr; 2021 Apr; 1863(4):183536. PubMed ID: 33373595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
